5,7-dimethyl-18-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-16-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-9-oxa-6,12-diazapentacyclo[11.7.0.02,10.03,8.014,19]icosa-1,3(8),4,6,10,12,14(19),15,17-nonaene
C75H66N6O2 — CID 176823156
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5,7-dimethyl-18-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-16-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-9-oxa-6,12-diazapentacyclo[11.7.0.02,10.03,8.014,19]icosa-1,3(8),4,6,10,12,14(19),15,17-nonaene
5,7-dimethyl-18-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-16-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-9-oxa-6,12-diazapentacyclo[11.7.0.02,10.03,8.014,19]icosa-1,3(8),4,6,10,12,14(19),15,17-nonaene (PubChem CID 176823156) has the molecular formula C75H66N6O2 and a molecular weight of 1083.39 g/mol. Its IUPAC name is 5,7-dimethyl-18-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-16-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-9-oxa-6,12-diazapentacyclo[11.7.0.02,10.03,8.014,19]icosa-1,3(8),4,6,10,12,14(19),15,17-nonaene.
Molecular Properties
| Compound Name | 5,7-dimethyl-18-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-16-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-9-oxa-6,12-diazapentacyclo[11.7.0.02,10.03,8.014,19]icosa-1,3(8),4,6,10,12,14(19),15,17-nonaene |
|---|---|
| PubChem CID | 176823156 |
| Molecular Formula | C75H66N6O2 |
| Molecular Weight | 1083.39 g/mol |
| Exact Mass | 1082.52 |
| IUPAC Name | 5,7-dimethyl-18-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-16-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-9-oxa-6,12-diazapentacyclo[11.7.0.02,10.03,8.014,19]icosa-1,3(8),4,6,10,12,14(19),15,17-nonaene |
| SMILES | Cc1cc2c(oc3cnc4c(c32)Cc2c-4cc(Oc3cccc(-c4nc5ccccc5n4-c4c(C(C)C)cc(-c5ccccc5)cc4C(C)C)c3)cc2-c2nc3ccccc3n2-c2c(C(C)C)cc(-c3ccccc3)cc2C(C)C)c(C)n1 |
| InChI | InChI=1S/C75H66N6O2/c1-42(2)55-34-51(48-22-13-11-14-23-48)35-56(43(3)4)71(55)80-66-30-19-17-28-64(66)78-74(80)50-26-21-27-53(33-50)82-54-38-60-59(40-62-69-63-32-46(9)77-47(10)73(63)83-68(69)41-76-70(60)62)61(39-54)75-79-65-29-18-20-31-67(65)81(75)72-57(44(5)6)36-52(37-58(72)45(7)8)49-24-15-12-16-25-49/h11-39,41-45H,40H2,1-10H3 |
| InChIKey | NZEBPTYGKOFCAE-UHFFFAOYSA-N |
| XLogP | 20.20 |
| TPSA | 83.79 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 83 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1083.39 |
| LogP ≤ 5 | 20.20 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176823156 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.